These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 30204862)
1. Plastin 3 influences bone homeostasis through regulation of osteoclast activity. Neugebauer J; Heilig J; Hosseinibarkooie S; Ross BC; Mendoza-Ferreira N; Nolte F; Peters M; Hölker I; Hupperich K; Tschanz T; Grysko V; Zaucke F; Niehoff A; Wirth B Hum Mol Genet; 2018 Dec; 27(24):4249-4262. PubMed ID: 30204862 [TBL] [Abstract][Full Text] [Related]
2. PLS3 mutations in X-linked osteoporosis with fractures. van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043 [TBL] [Abstract][Full Text] [Related]
3. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798 [TBL] [Abstract][Full Text] [Related]
4. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis. Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159 [TBL] [Abstract][Full Text] [Related]
5. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189 [TBL] [Abstract][Full Text] [Related]
7. Osteoclast-specific Plastin 3 knockout in mice fail to develop osteoporosis despite dramatic increased osteoclast resorption activity. Maus I; Dreiner M; Zetzsche S; Metzen F; Ross BC; Mählich D; Koch M; Niehoff A; Wirth B JBMR Plus; 2024 Jan; 8(1):ziad009. PubMed ID: 38549711 [No Abstract] [Full Text] [Related]
8. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3. Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384 [TBL] [Abstract][Full Text] [Related]
9. Plastin 3 in health and disease: a matter of balance. Wolff L; Strathmann EA; Müller I; Mählich D; Veltman C; Niehoff A; Wirth B Cell Mol Life Sci; 2021 Jul; 78(13):5275-5301. PubMed ID: 34023917 [TBL] [Abstract][Full Text] [Related]
10. Mice lacking plastin-3 display a specific defect of cortical bone acquisition. Yorgan TA; Sari H; Rolvien T; Windhorst S; Failla AV; Kornak U; Oheim R; Amling M; Schinke T Bone; 2020 Jan; 130():115062. PubMed ID: 31678489 [TBL] [Abstract][Full Text] [Related]
11. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations. Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of p.Ala253_Leu254insAsn mutation in PLS3 responsible for X-linked osteoporosis. Wang L; Zhai Q; Zhao P; Xiang X; Zhang X; Tian W; Li T Clin Genet; 2018 Jan; 93(1):178-181. PubMed ID: 28646489 [TBL] [Abstract][Full Text] [Related]
13. A novel frameshift deletion in PLS3 causing severe primary osteoporosis. Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797 [TBL] [Abstract][Full Text] [Related]
14. Impaired bone strength and bone microstructure in a novel early-onset osteoporotic rat model with a clinically relevant Hu J; Zhou B; Lin X; Zhang Q; Guan F; Sun L; Liu J; Wang O; Jiang Y; Xia WB; Xing X; Li M Elife; 2023 Apr; 12():. PubMed ID: 37083757 [TBL] [Abstract][Full Text] [Related]
15. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1. Chen W; Zhu G; Tang J; Zhou HD; Li YP J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis. Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817 [TBL] [Abstract][Full Text] [Related]
17. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis. Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women. Shao C; Wang YW; He JW; Fu WZ; Wang C; Zhang ZL Acta Pharmacol Sin; 2019 Sep; 40(9):1212-1218. PubMed ID: 30837644 [TBL] [Abstract][Full Text] [Related]
19. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization. Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485 [TBL] [Abstract][Full Text] [Related]
20. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]